Suppression of T Cell Responses by Chondromodulin I, a Cartilage-Derived Angiogenesis Inhibitory Factor: Therapeutic Potential in Rheumatoid Arthritis

Arthritis and Rheumatism

Volumn 50, Issue 3, 2004, Pages 828-839

  Setoguchi, Keigo ^a   Misaki, Yoshikata ^a   Kawahata, Kimito ^a   Shimada, Kota ^a   Juji, Takuo ^a   Tanaka, Sakae ^a   Oda, Hiromi ^a   Shukunami, Chisa ^b   Nishizaki, Yuriko ^b   Hiraki, Yuji ^b   Yamamoto, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CHONDROMODULIN I; COMPLEMENTARY DNA; PROTEOGLYCAN; RECOMBINANT CHONDROMODULIN I; RNA; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTHRITIS; ARTICLE; CARTILAGE CELL; CELL VIABILITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EXTRACELLULAR MATRIX; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE; THYMUS;

ADJUVANTS, IMMUNOLOGIC; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODY FORMATION; ANTIGENS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CARTILAGE; CELL DIVISION; CELL LINE; COLLAGEN; EPITOPES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; THYMUS GLAND; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 12144286678     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20193     Document Type: Article

References (54)

1. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
2. Van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975;293:517-20.
3. Misaki Y, Ezaki I, Yamamoto K. T cell clonality in the rheumatic diseases. APLAR J Rheum 1998;1:194-7.
4. Struyk L, Hawes GE, Chatila MK, Breedveld FC, Kurnick JT, van den Elsen PJ. T cell receptors in rheumatoid arthritis. Arthritis Rheum 1995;38:577-89.
5. Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 1996;97:1335-43.
6. Yamamoto K, Sakoda H, Nakajima T, Kato T, Okubo M, Dohi M, et al. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol 1992;4:1219-23.
7. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, et al. HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 1989;32:15-21.
8. Weyand CM, Goronzy JJ. HLA polymorphisms and T cells in rheumatoid arthritis. Int Rev Immunol 1999;18:37-59.
9. Weyand CM, Goronzy JJ. T-cell responses in rheumatoid arthritis: systemic abnormalities, local disease. Curr Opin Rheumatol 1999;11:210-7.
10. Firestein GS. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest 1999;103:3-4.
11. Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998;41:951-62.
12. FitzGerald O, Soden M, Yanni G, Robinson R, Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:792-6.
13. Gibaldi M. Regulating angiogenesis: a new therapeutic strategy. J Clin Pharm 1998;38:898-903.
14. Peacock DJ, Banquerigo ML, Brahn E. Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 1992;175:1135-8.
15. Peacock DJ, Banquerigo ML, Brahn E. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol 1995;160:178-84.
16. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an αv/β3 antagonist. J Clin Invest 1999;103:47-54.
17. Lutten A, Tjwa M, Moons L,Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002;8:831-40.
18. Kim JM, Ho SH, Park EJ, Hahn W, Cho H, Jeong JG, et al. Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis. Arthritis Rheum 2002;46:793-801.
19. Yin G, Liu W, An P, Li P, Ding I, Planelles V, et al. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol Ther 2002;5:547-54.
20. Kim HA, Song YW. Apoptotic chondrocyte death in rheumatoid arthritis. Arthritis Rheum 1999;42:1528-37.
21. Jorgensen C, Noel D, Apparailly F, Sany J. Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 2001;60:305-9.
22. Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor: purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997;272:32419-26.
23. Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F. Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes Biochem Biophys Res Commun 1991;175:971-7.
24. Inoue H, Kondo J, Koike T, Shukunami C, Hiraki Y. Identification of an autocrine chondrocyte colony-stimulating factor: chondromodulin-I stimulates colony formation of growth plate chondrocytes in agarose culture. Biochem Biophys Res Commun 1997;241:395-400.
25. Hiraki Y, Mitsui K, Endo N, Takahashi K, Hayami T, Inoue H, et al. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur J Biochem 1999;260:869-78.
26. Shukunami C, Iyama K, Inoue H, Hiraki Y. Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int J Dev Biol 1999;43:39-49.
27. Hayami T, Shukunami C, Mitsui K, Endo N, Tokunaga K, Kondo J, et al. Nucleotide, protein specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett 1999;458:436-40.
28. lo thymocytes in vivo. Science 1990;250:1720-3.
29. Stanciu LA, Shute J, Holgate ST, Djukanovic R. Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting. J Immunol Methods 1996;189:107-15.
30. Setoguchi K, Misaki Y, Terauchi Y, Yamauchi T, Kawahata K, Kadowaki T, et al. Peroxisome proliferator-activated receptor-γ haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J Clin Invest 2001;108:1667-75.
31. Xie L, Chesterman CN, Hogg PJ. Reduction of von Willebrand factor by endothelial cells. Thromb Haemost 2000;84:506-13.
32. Xie L, Chesterman CN, Hogg PJ. Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med 2001;193:1341-50.
33. Goto M, Sasano M, Yamanaka H, Miyasaka N, Kamatani N, Inoue K, et al. Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 1987;80:786-96.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
35. Satoh K, Kikuchi S, Sekimata M, Kabuyama Y, Homma MK, Homma Y. Involvement of ErbB-2 in rheumatoid synovial cell growth. Arthritis Rheum 2001;44:260-5.
36. Setoguchi K, Misaki Y, Araki Y, Fujio K, Kawahata K, Kitamura T, et al. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J Immunol 2000;165:5980-6.
37. Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 1982;69:673-83.
38. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-68.
39. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
40. Joosten LA, Lubberts E, Dure P, Helsen MM, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
41. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint diseases in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;89:9784-8.
42. Brackertz D, Mitchell GF, Mackay IR. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 1977;20:841-50.
43. Hietala MA, Jonsson IM, Tarkowski A, Kleinau S, Pekna M. Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol 2002;169:454-9.
44. Baeten D, Boots AM, Steenbakkers PG, Elewaut D, Bos E, Verheijden GF, et al. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000;6:1233-43.
45. Glant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum 1998;41:1007-18.
46. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Leroux JY, Rosenberg LC, et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 1998;41:1019-25.
47. Leroux JY, Guerassimov A, Cartman A, Delaunay N, Webber C, Rosenberg LC, et al. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/ c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J Clin Invest 1996;97:621-32.
48. Zhang Y, Guerassimov A, Leroux JY, Cartman A, Webber C, Lalic R, et al. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice: evidence for T cell involvement and the immunosuppressive influence of keratan sulfate on recognition of T and B cell epitopes. J Clin Invest 1998;101:1678-86.
49. Hansson AS, Heinegard D, Holmdahl R. A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest 1999;104:589-98.
50. Blass S, Schumann F, Hain NA, Engel JM, Stuhlmuller B, Burmester GR. p205 is a major target of autoreactive T cells in rheumatoid arthritis. Arthritis Rheum 1999;42:971-80.
51. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-7.
52. McRae BL, Vanderlugt CL, DalCanto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
53. Tuohy VK, Yu M, Yin L, Kawczak JA, Johnson JM, Mathisen PM, et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1998;164:93-100.
54. Azizan A, Gaw JU, Govindraj P, Tapp H, Neame PJ. Chondromodulin I and pleiotrophin gene expression in bovine cartilage and epiphysis. Matrix Biol 2000;19:521-31.